These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 18721806)

  • 21. Novel targets for lung cancer therapy: part I.
    Dy GK; Adjei AA
    J Clin Oncol; 2002 Jun; 20(12):2881-94. PubMed ID: 12065566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HER3 receptor and its role in the therapeutic management of metastatic breast cancer.
    Zhu M; Yu M; Meng Y; Yang J; Wang X; Li L; Liang Y; Kong F
    J Transl Med; 2024 Jul; 22(1):665. PubMed ID: 39020378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms and therapeutic targets of ErbB family receptors in hepatocellular carcinoma: a narrative review.
    Qiang Z; Wan J; Chen X; Wang H
    Transl Cancer Res; 2024 Jun; 13(6):3156-3178. PubMed ID: 38988928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of ERBB Signaling Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma and Establishing a Prognostic Risk Assessment Model for Patients.
    Wang Z; Li J; Zhang P; Zhao L; Huang B; Xu Y; Wu G; Xia Q
    Front Genet; 2022; 13():862210. PubMed ID: 35903358
    [No Abstract]   [Full Text] [Related]  

  • 25. The Role of EREG/EGFR Pathway in Tumor Progression.
    Cheng WL; Feng PH; Lee KY; Chen KY; Sun WL; Van Hiep N; Luo CS; Wu SM
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumour immunity regulated by aberrant ERBB family signalling.
    Kumagai S; Koyama S; Nishikawa H
    Nat Rev Cancer; 2021 Mar; 21(3):181-197. PubMed ID: 33462501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A conformational sensor based on genetic code expansion reveals an autocatalytic component in EGFR activation.
    Baumdick M; Gelléri M; Uttamapinant C; Beránek V; Chin JW; Bastiaens PIH
    Nat Commun; 2018 Sep; 9(1):3847. PubMed ID: 30242154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual targeting of HER3 and MEK may overcome HER3-dependent drug-resistance of colon cancers.
    Bon G; Loria R; Amoreo CA; Verdina A; Sperduti I; Mastrofrancesco A; Soddu S; Diodoro MG; Mottolese M; Todaro M; Stassi G; Milella M; De Maria R; Falcioni R
    Oncotarget; 2017 Dec; 8(65):108463-108479. PubMed ID: 29312543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Organotypic three-dimensional cancer cell cultures mirror drug responses
    Jacobi N; Seeboeck R; Hofmann E; Schweiger H; Smolinska V; Mohr T; Boyer A; Sommergruber W; Lechner P; Pichler-Huebschmann C; Önder K; Hundsberger H; Wiesner C; Eger A
    Oncotarget; 2017 Dec; 8(64):107423-107440. PubMed ID: 29296175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-152 is involved in the proliferation and metastasis of ovarian cancer through repression of ERBB3.
    Li LW; Xiao HQ; Ma R; Yang M; Li W; Lou G
    Int J Mol Med; 2018 Mar; 41(3):1529-1535. PubMed ID: 29286064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endobronchial ultrasound guided transbronchial needle aspiration combining with immunohistochemistry and genotype in lung cancer: A single-center, 55 cases retrospective study.
    Liu A; Qian L; Zhong Y; Lu X; Zhao Y
    Ann Med Surg (Lond); 2017 Nov; 23():1-7. PubMed ID: 28951780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology.
    Jacobi N; Seeboeck R; Hofmann E; Eger A
    Cancers (Basel); 2017 Apr; 9(4):. PubMed ID: 28417948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Next-generation sequencing of non-small cell lung cancer using a customized, targeted sequencing panel: Emphasis on small biopsy and cytology.
    DiBardino DM; Rawson DW; Saqi A; Heymann JJ; Pagan CA; Bulman WA
    Cytojournal; 2017; 14():7. PubMed ID: 28413430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Histopathological Feature of EGFR-Mutated Lung Adenocarcinomas with Highly Malignant Potential - An Implication of Micropapillary Element.
    Matsumura M; Okudela K; Kojima Y; Umeda S; Tateishi Y; Sekine A; Arai H; Woo T; Tajiri M; Ohashi K
    PLoS One; 2016; 11(11):e0166795. PubMed ID: 27861549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May Benefit From Enrollment in Mechanism-Driven Clinical Trials.
    Suh JH; Johnson A; Albacker L; Wang K; Chmielecki J; Frampton G; Gay L; Elvin JA; Vergilio JA; Ali S; Miller VA; Stephens PJ; Ross JS
    Oncologist; 2016 Jun; 21(6):684-91. PubMed ID: 27151654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a novel HER3 activating mutation homologous to EGFR-L858R in lung cancer.
    Umelo I; Noeparast A; Chen G; Renard M; Geers C; Vansteenkiste J; Giron P; De Wever O; Teugels E; De Grève J
    Oncotarget; 2016 Jan; 7(3):3068-83. PubMed ID: 26689995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of sialylation on EGFR phosphorylation and resistance to tyrosine kinase inhibition.
    Yen HY; Liu YC; Chen NY; Tsai CF; Wang YT; Chen YJ; Hsu TL; Yang PC; Wong CH
    Proc Natl Acad Sci U S A; 2015 Jun; 112(22):6955-60. PubMed ID: 25971727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diagnosis and treatment of brain metastases in EGFR mutant lung cancer.
    Minchom A; Yu KC; Bhosle J; O'Brien M
    CNS Oncol; 2014 May; 3(3):209-17. PubMed ID: 25055129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Met in lung cancer.
    Dent P
    Cancer Biol Ther; 2014 Jun; 15(6):653-4. PubMed ID: 24618893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EV20, a Novel Anti-ErbB-3 Humanized Antibody, Promotes ErbB-3 Down-Regulation and Inhibits Tumor Growth In Vivo.
    Sala G; Rapposelli IG; Ghasemi R; Piccolo E; Traini S; Capone E; Rossi C; Pelliccia A; Di Risio A; D'Egidio M; Tinari N; Muraro R; Iacobelli S;
    Transl Oncol; 2013 Dec; 6(6):676-84. PubMed ID: 24466370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.